Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Corinne Pankovcin net worth and biography

Corinne Pankovcin Biography and Net Worth

CFO of Aditxt

Served as Chief Financial Officer for several world class organizations including; Business Development Corporation of America (“BDCA”), BlackRock Kelso Capital (NASDAQ BKCC) and AIG Capital Partners. Responsible for executing portfolio investments and managing significant M&A transactions throughout her career.

What is Corinne Pankovcin's net worth?: The estimated net worth of Corinne Pankovcin is at least $6,766.35 as of May 25th, 2021. Ms. Pankovcin owns 2,855 shares of Aditxt stock worth more than $6,766 as of April 18th. This net worth estimate does not reflect any other investments that Ms. Pankovcin may own. Additionally, Ms. Pankovcin receives a salary of $366,770.00 as CFO at Aditxt. Learn More about Corinne Pankovcin's net worth.
How old is Corinne Pankovcin?: Ms. Pankovcin is currently 58 years old. There are 3 older executives and no younger executives at Aditxt. The oldest executive at Aditxt is Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D., Co-Founder, Chief Innovation Officer, Secretary & Director, who is 61 years old. Learn More on Corinne Pankovcin's age.
What is Corinne Pankovcin's salary?: As the CFO of Aditxt, Inc., Ms. Pankovcin earns $366,770.00 per year. The highest earning executive at Aditxt is Mr. Amro A. Albanna, Co-Founder, Chairman & CEO, who commands a salary of $472,120.00 per year. Learn More on Corinne Pankovcin's salary.
How do I contact Corinne Pankovcin?: The corporate mailing address for Ms. Pankovcin and other Aditxt executives is 2569 WYANDOTTE ST. SUITE 101, MOUNTAIN CA, 94043. Aditxt can also be reached via phone at 650-870-1200 and via email at [email protected]. Learn More on Corinne Pankovcin's contact information.
Has Corinne Pankovcin been buying or selling shares of Aditxt?: Corinne Pankovcin has not been actively trading shares of Aditxt within the last three months. Most recently, on Tuesday, May 25th, Corinne Pankovcin bought 105 shares of Aditxt stock. The stock was acquired at an average cost of $102.40 per share, with a total value of $10,752.00. Following the completion of the transaction, the chief financial officer now directly owns 2,855 shares of the company's stock, valued at $292,352. Learn More on Corinne Pankovcin's trading history.
Who are Aditxt's active insiders?: Aditxt's insider roster includes Thomas Farley (Insider), Corinne Pankovcin (CFO), and Shahrokh Shabahang (Insider). Learn More on Aditxt's active insiders.
Are insiders buying or selling shares of Aditxt?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 20,800 shares worth more than $691,184.00. The most recent insider tranaction occured on September, 7th when Major Shareholder Paribas Securities Corp Bnp sold 20,800 shares worth more than $691,184.00. Insiders at Aditxt own 1.2% of the company. Learn More about insider trades at Aditxt.
Information on this page was last updated on 9/7/2023.

Corinne Pankovcin Insider Trading History at Aditxt

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/25/2021	Buy	105	$102.40	$10,752.00	2,855

Corinne Pankovcin Buying and Selling Activity at Aditxt

Aditxt Company Overview

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. It is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Today's Range

Now: $2.37

$2.35

$2.55

50 Day Range

MA: $3.40

$2.35

$4.00

2 Week Range

Now: $2.37

$2.31

$76.40

Volume

36,119 shs

Average Volume

362,073 shs

Market Capitalization

$568,800.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Corinne Pankovcin Biography and Net Worth

What is Corinne Pankovcin's net worth?

How old is Corinne Pankovcin?

What is Corinne Pankovcin's salary?

How do I contact Corinne Pankovcin?

Has Corinne Pankovcin been buying or selling shares of Aditxt?

Who are Aditxt's active insiders?

Are insiders buying or selling shares of Aditxt?